搜尋
WAVE Life Sciences Ltd
WVE添加自選
6.260USD
+0.420+7.19%
收盤 07/02, 13:00（美東）報價延遲15分鐘
1.20B總市值
虧損本益比TTM
關於 WAVE Life Sciences Ltd 公司
Wave Life Sciences Ltd. is a biotechnology company focused on unlocking the broad potential of ribonucleic acid (RNA) medicines to transform human health. The Company’s RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. The Company’s diversified pipeline includes clinical programs in alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington’s disease, as well as several preclinical programs utilizing the Company’s broad RNA therapeutics toolkit. Its programs include WVE-006, SERPINA1 (AATD); WVE-007 (GalNAc), INHBE (Obesity); WVE-N531, Exon 53 (DMD), and WVE-003, mHTT (HD).
WAVE Life Sciences Ltd簡介
公司代碼WVE
公司名稱WAVE Life Sciences Ltd
上市日期Nov 11, 2015
CEOBolno (Paul B)
員工數量287
證券類型Ordinary Share
年結日Nov 11
公司地址7 Straits View
城市
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Singapore
郵編018936
電話6562363388
網址https://www.wavelifesciences.com/
公司代碼WVE
上市日期Nov 11, 2015
CEOBolno (Paul B)
WAVE Life Sciences Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Chandra Vargeese, Ph.D.
Dr. Chandra Vargeese, Ph.D.
Chief Technology Officer, Head - Platform Discovery Sciences
Chief Technology Officer, Head - Platform Discovery Sciences
334.87K
-2.94%
Mr. Kyle Moran
Mr. Kyle Moran
Chief Financial Officer
Chief Financial Officer
57.26K
-79.88%
Dr. Christopher I. Wright, M.D., Ph.D.
Dr. Christopher I. Wright, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
45.63K
--
Ms. Heidi L. Wagner, J.D.
Ms. Heidi L. Wagner, J.D.
Independent Director
Independent Director
16.11K
-78.81%
Mr. Ken Takanashi
Mr. Ken Takanashi
Independent Director
Independent Director
11.24K
-112.96%
Dr. Christopher John Francis, Ph.D.
Dr. Christopher John Francis, Ph.D.
Senior Vice President - Corporate Development, Head - Emerging Areas
Senior Vice President - Corporate Development, Head - Emerging Areas
4.37K
-744.22%
Dr. Mark H. N. Corrigan, M.D.
Dr. Mark H. N. Corrigan, M.D.
Independent Director
Independent Director
--
--
Ms. Aik Na Tan
Ms. Aik Na Tan
Independent Director
Independent Director
--
-100.00%
Dr. Paul B. Bolno, M.D.
Dr. Paul B. Bolno, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Gregory L. (Greg) Verdine, Ph.D.
Dr. Gregory L. (Greg) Verdine, Ph.D.
Director
Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Chandra Vargeese, Ph.D.
Dr. Chandra Vargeese, Ph.D.
Chief Technology Officer, Head - Platform Discovery Sciences
Chief Technology Officer, Head - Platform Discovery Sciences
334.87K
-2.94%
Mr. Kyle Moran
Mr. Kyle Moran
Chief Financial Officer
Chief Financial Officer
57.26K
-79.88%
Dr. Christopher I. Wright, M.D., Ph.D.
Dr. Christopher I. Wright, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
45.63K
--
Ms. Heidi L. Wagner, J.D.
Ms. Heidi L. Wagner, J.D.
Independent Director
Independent Director
16.11K
-78.81%
Mr. Ken Takanashi
Mr. Ken Takanashi
Independent Director
Independent Director
11.24K
-112.96%
Dr. Christopher John Francis, Ph.D.
Dr. Christopher John Francis, Ph.D.
Senior Vice President - Corporate Development, Head - Emerging Areas
Senior Vice President - Corporate Development, Head - Emerging Areas
4.37K
-744.22%
常見問題
WAVE Life Sciences Ltd的前五大股東是誰？
WAVE Life Sciences Ltd的前五大股東如下：Dr. Chandra Vargeese, Ph.D.